Adeno-associated viral vector encoding vascular endothelial growth factor gene: Effect on cardiovascular MR perfusion and infarct resorption measurements in swine

被引:29
作者
Saeed, Maythem
Saloner, David
Martin, Alastair
Do, Loi
Weber, Oliver
Ursell, Philip C.
Jacquier, Alexis
Lee, Randall
Higgins, Charles B.
机构
[1] Univ Calif San Francisco, Dept Radiol, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Dept Med Cardiol, San Francisco, CA 94143 USA
关键词
D O I
10.1148/radiol.2432060928
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: To prospectively determine in swine the effects of cardiac-specific and hypoxia-inducible vascular endothelial growth factor ( VEGF) expression gene on angiogenesis and arteriogenesis by using cardiovascular magnetic resonance ( MR) imaging for evaluation of infarct resorption and left ventricular ( LV) function. Materials and Methods: The investigation conformed to U. S. National Institutes of Health guidelines. Twelve pigs with reperfused infarcts were studied with cardiovascular MR 3 days and 8 weeks after surgery. In six pigs, adeno-associated viral ( AAV) vector-encoding VEGF ( AAV-VEGF) gene was injected at eight sites 1 hour after reperfusion. Six pigs served as controls. Cardiovascular MR measurements of perfusion, area at risk, infarct size, and LV function were used in evaluation of the therapy. Hematoxylin-eosin, Masson trichrome, and biotinylated isolectin B4 stains were used to assess regional vascular density. Two-way Student t test was used to determine significant differences between means. Results: AAV-VEGF had no effect on cardiovascular MR perfusion or infarct size measurements 3 days after infarction. At 8 weeks, the therapy increased infarct resorption, perfusion, and vascular density and prevented deterioration of ejection fraction in treated animals. These changes were associated with a significantly greater reduction in extent of enhanced region in treated ( 18.6% of LV surface area +/- 1.5 [ standard error of mean] to 9.8% +/- 1.1) than in control animals ( 17.7% +/- 1.8 to 14.5% +/- 1.5, P =.028). Histopathologic findings in treated animals showed increased capillary and arterial density in infarct and periinfarct regions. These new vessels were active and thin-walled compared with thick-walled vessels of control animals. Conclusion: AAV-VEGF improves cardiovascular MR measurement of regional myocardial perfusion and LV function. (c) RSNA, 2007.
引用
收藏
页码:451 / 460
页数:10
相关论文
共 53 条
[1]   Assessment of the tissue distribution of transplanted human endothelial progenitor cells by radioactive labeling [J].
Aicher, A ;
Brenner, W ;
Zuhayra, M ;
Badorff, C ;
Massoudi, S ;
Assmus, B ;
Eckey, T ;
Henze, E ;
Zeiher, AM ;
Dimmeler, S .
CIRCULATION, 2003, 107 (16) :2134-2139
[2]   Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium - Feasibility, cell migration, and body distribution [J].
Barbash, IM ;
Chouraqui, P ;
Baron, J ;
Feinberg, MS ;
Etzion, S ;
Tessone, A ;
Miller, L ;
Guetta, E ;
Zipori, D ;
Kedes, LH ;
Kloner, RA ;
Leor, J .
CIRCULATION, 2003, 108 (07) :863-868
[3]  
BATTEGAY EJ, 1995, J MOL MED, V73, P333
[4]   Intramyocardial and intracoronary basic fibroblast growth factor in porcine hibernating myocardium: A comparative study [J].
Biswas, SS ;
Hughes, GC ;
Scarborough, JE ;
Domkowski, PW ;
Diodato, L ;
Smith, ML ;
Landolfo, C ;
Lowe, JE ;
Annex, BH ;
Landolfo, KP .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2004, 127 (01) :34-43
[5]   1ST-PASS ENTRY OF NONIONIC CONTRAST AGENT INTO THE MYOCARDIAL EXTRAVASCULAR SPACE - EFFECTS ON RADIOGRAPHIC ESTIMATES OF TRANSIT-TIME AND BLOOD-VOLUME [J].
CANTY, JM ;
JUDD, RM ;
BRODY, AS ;
KLOCKE, FJ .
CIRCULATION, 1991, 84 (05) :2071-2078
[6]   Infarct involution and improved function during healing of acute myocardial infarction: The role of microvascular obstruction [J].
Choi, CJ ;
Haji-Momenian, S ;
DiMaria, JM ;
Epstein, FH ;
Bove, CM ;
Rogers, WJ ;
Kramer, CM .
JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE, 2004, 6 (04) :917-925
[7]   Recombinant adeno-associated virus type 2, 4, and 5 vectors: Transduction of variant cell types and regions in the mammalian central nervous system [J].
Davidson, BL ;
Stein, CS ;
Heth, JA ;
Martins, I ;
Kotin, RM ;
Derksen, TA ;
Zabner, J ;
Ghodsi, A ;
Chiorini, JA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (07) :3428-3432
[8]   Adeno-associated virus-mediated transduction of VEGF165 improves cardiac tissue viability and functional recovery after permanent coronary occlusion in conscious dogs [J].
Ferrarini, M ;
Arsic, N ;
Recchia, FA ;
Zentilin, L ;
Zacchigna, S ;
Xu, XB ;
Linke, A ;
Giacca, M ;
Hintze, TH .
CIRCULATION RESEARCH, 2006, 98 (07) :954-961
[9]   Infarct resorption, compensatory hypertrophy, and differing patterns of ventricular remodeling following myocardial infarctions of varying size [J].
Fieno, DS ;
Hillenbrand, HB ;
Rehwald, WG ;
Harris, KR ;
Decker, RS ;
Parker, MA ;
Klocke, FJ ;
Kim, RJ ;
Judd, RM .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (11) :2124-2131
[10]   Recombinant adeno-associated virus for muscle directed gene therapy [J].
Fisher, KJ ;
Jooss, K ;
Alston, J ;
Yang, YP ;
Haecker, SE ;
High, K ;
Pathak, R ;
Raper, SE ;
Wilson, JM .
NATURE MEDICINE, 1997, 3 (03) :306-312